SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-19-007310
Filing Date
2019-04-16
Accepted
2019-04-16 16:30:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A opfin20190416_sc13da.htm SC 13D/A 40086
  Complete submission text file 0001437749-19-007310.txt   41610
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 19751307
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27/F, TWO EXCHANGE SQUARE 8 CONNAUGHT PLACE CENTRAL K3 00000
Business Address 27/F, TWO EXCHANGE SQUARE 8 CONNAUGHT PLACE CENTRAL K3 00000 85228425888
OP Financial Ltd (Filed by) CIK: 0001740508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13D/A